Financial Year |
March 31 2023 |
Monetary Funds |
1,199,459,615.73 |
Held-for-trading Financial Assets |
211,590,075.00 |
Notes Receivable |
7,208,336.96 |
Accounts Receivable |
1,107,543,242.29 |
Advances to Suppliers |
548,004,449.01 |
Other Receivables |
323,462,608.91 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
17,582,194.08 |
Inventories |
1,111,919,364.28 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
59,314,682.64 |
Total Current Assets |
4,571,556,788.58 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
541,605,833.19 |
Investment Properties |
-- |
Fixed Assetes |
887,515,557.17 |
Under-construction Projects |
188,977,769.89 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
727,571,289.46 |
Oil and Gas Assets |
-- |
Intangible Assets |
217,459,010.86 |
R&D expenses |
-- |
Goodwill |
65,087,061.18 |
Long-Term Deferred and Prepaid Expenses |
33,162,298.79 |
Deferred Income Tax Assets |
99,196,928.22 |
Other Non-Current Assets |
144,909,939.12 |
Sub-Total of Non-Current Assets |
5,808,724,677.59 |
Total Assets |
10,380,281,466.17 |
Short-Term Loans |
3,054,821,790.50 |
Trading Financial liabilities |
-- |
Notes Payable |
206,425,965.00 |
Accounts Payable |
485,842,956.48 |
Accounts Received In Advance |
71,068.15 |
Employee Compensation Payable |
93,179,241.68 |
Taxes Payable |
56,284,548.82 |
Interest Payable |
-- |
Dividend Payable |
5,413,575.94 |
Other payables |
499,042,711.02 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
33,904,794.91 |
Other Current Liabilities |
18,028,875.82 |
Sub-Total of Current Liabilities |
4,840,688,330.55 |
Long-term Loans |
205,749,950.79 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
5,000,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
23,104,527.99 |
Deferred Income Tax Liabilities |
107,356,635.44 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,035,283,043.20 |
Total Liabilities |
5,875,971,373.75 |
Paid-In Capital(Or Share Stock) |
995,041,427.00 |
Capital Surplus |
712,923,529.15 |
Surplus Reserve |
197,023,134.78 |
LESS:Treasury Stock |
55,667,481.21 |
Undistributed Profits |
1,542,323,357.76 |
Minority Stockholder's Interest |
613,051,894.35 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,891,258,198.07 |
Owner's Equity(Stockholder's Equity) |
4,504,310,092.42 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
10,380,281,466.17 |